MX2019001910A - Metodo preventivo o terapeutico de diarrea epidemica porcina, vacuna, y kit de vacuna. - Google Patents

Metodo preventivo o terapeutico de diarrea epidemica porcina, vacuna, y kit de vacuna.

Info

Publication number
MX2019001910A
MX2019001910A MX2019001910A MX2019001910A MX2019001910A MX 2019001910 A MX2019001910 A MX 2019001910A MX 2019001910 A MX2019001910 A MX 2019001910A MX 2019001910 A MX2019001910 A MX 2019001910A MX 2019001910 A MX2019001910 A MX 2019001910A
Authority
MX
Mexico
Prior art keywords
vaccine
epidemic diarrhea
porcine epidemic
preventative
therapeutic method
Prior art date
Application number
MX2019001910A
Other languages
English (en)
Inventor
Sato Tetsuo
Oroku Kazuki
Ohshima Yoshiyuki
Furuya Yoshiaki
Tsutsumi Nobuyuki
Original Assignee
Nippon Inst For Biological Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Inst For Biological Science filed Critical Nippon Inst For Biological Science
Publication of MX2019001910A publication Critical patent/MX2019001910A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A61K39/225—Porcine transmissible gastroenteritis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un método para prevenir o tratar diarrea epidémica porcina, el método incluye: administrar una vacuna viva de un virus de diarrea epidémica porcina y un adyuvante a un cerdo a través de administración oral o administración nasal; y administrar una vacuna desactivada del virus de diarrea epidémica porcina y un adyuvante al cerdo a través de administración intramuscular.
MX2019001910A 2016-08-17 2017-07-24 Metodo preventivo o terapeutico de diarrea epidemica porcina, vacuna, y kit de vacuna. MX2019001910A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016159797A JP6253210B1 (ja) 2016-08-17 2016-08-17 豚流行性下痢の予防又は治療方法、ワクチン、及びワクチンキット
PCT/JP2017/026692 WO2018034106A1 (ja) 2016-08-17 2017-07-24 豚流行性下痢の予防又は治療方法、ワクチン、及びワクチンキット

Publications (1)

Publication Number Publication Date
MX2019001910A true MX2019001910A (es) 2019-05-15

Family

ID=60860075

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019001910A MX2019001910A (es) 2016-08-17 2017-07-24 Metodo preventivo o terapeutico de diarrea epidemica porcina, vacuna, y kit de vacuna.

Country Status (12)

Country Link
US (1) US11013797B2 (es)
EP (1) EP3501535B1 (es)
JP (1) JP6253210B1 (es)
KR (1) KR102439665B1 (es)
BR (1) BR112019003126A2 (es)
CA (1) CA3033730A1 (es)
DK (1) DK3501535T5 (es)
ES (1) ES2965854T3 (es)
MX (1) MX2019001910A (es)
PH (1) PH12019500330A1 (es)
TW (1) TWI770041B (es)
WO (1) WO2018034106A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11413347B2 (en) 2019-09-02 2022-08-16 Reber Genetics Co., Ltd. Vaccine composition and method of preventing porcine epidemic diarrhea virus infection in swine
CN111471658A (zh) * 2020-04-16 2020-07-31 武汉科前生物股份有限公司 一种病毒纯化方法及经由该方法制备得到的二联灭活疫苗
KR102484824B1 (ko) * 2020-09-03 2023-01-05 주식회사 중앙백신연구소 동물용 미끼백신 및 이의 제조방법
CN115074334B (zh) * 2021-03-15 2024-01-19 夏津新希望六和农牧有限公司 猪流行性腹泻病毒株、扩增培养方法、及其制备的疫苗组合物、制备方法和应用
CN113430177B (zh) * 2021-08-16 2022-09-02 山东信得科技股份有限公司 猪流行性腹泻病毒株、灭活疫苗、抗体及抗体的制备方法
CN116286679B (zh) * 2023-05-09 2023-08-01 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一株经分离得到的猪流行性腹泻病毒变异株及其应用
CN116966290B (zh) * 2023-07-17 2024-05-28 浙江洪晟生物科技股份有限公司 猪流行性腹泻灭活疫苗制备方法及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10218788A (ja) * 1997-02-07 1998-08-18 Natl Fedelation Of Agricult Coop Assoc 免疫増強剤の製造法および免疫増強法
ATE416788T1 (de) 2000-06-16 2008-12-15 Sembiosys Genetics Inc Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme
WO2004087204A2 (en) * 2003-04-04 2004-10-14 Pfizer Products Inc. Microfluidized oil-in-water emulsions and vaccine compositions
KR100622399B1 (ko) * 2004-01-14 2006-09-18 대한민국 불활화시킨 ｔｇｅｖ 및 ｐｅｄｖ을 함유하는 혼합불활화백신 및 그 제조방법
KR101442493B1 (ko) * 2014-02-21 2014-09-26 우진 비앤지 주식회사 돼지유행성설사병바이러스 약독화주 및 이를 포함하는 돼지유행성 설사병 백신 조성물
JP6395855B2 (ja) 2014-04-03 2018-09-26 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド ブタ流行性下痢ウイルスワクチン
LT3166634T (lt) * 2014-07-11 2021-11-10 Zoetis Services Llc Naujos vakcinos kompozicijos prieš kiaulių epideminės diarėjos virusą
CN104667269B (zh) * 2015-02-02 2018-01-09 广东海大畜牧兽医研究院有限公司 一种猪流行性腹泻病毒鼻腔免疫疫苗及其制备方法
KR101743142B1 (ko) * 2015-09-09 2017-06-02 강원대학교산학협력단 즉시 사용가능한 마이크로에멀젼 기반의 비강내 면역화용 면역보강제 조성물
KR101654023B1 (ko) * 2015-10-28 2016-09-06 우진 비앤지 주식회사 돼지유행성설사병바이러스 약독화주 및 불활화백신 조성물과 이를 이용한 경구 투여용 백신 조성물

Also Published As

Publication number Publication date
KR20190039204A (ko) 2019-04-10
BR112019003126A2 (pt) 2019-07-09
EP3501535A1 (en) 2019-06-26
KR102439665B1 (ko) 2022-09-02
ES2965854T3 (es) 2024-04-17
CA3033730A1 (en) 2018-02-22
US11013797B2 (en) 2021-05-25
WO2018034106A1 (ja) 2018-02-22
TW201825114A (zh) 2018-07-16
TWI770041B (zh) 2022-07-11
US20190209676A1 (en) 2019-07-11
EP3501535A4 (en) 2020-05-06
JP6253210B1 (ja) 2017-12-27
DK3501535T5 (da) 2024-09-02
PH12019500330A1 (en) 2019-11-11
DK3501535T3 (da) 2024-01-02
EP3501535B1 (en) 2023-09-20
JP2018027903A (ja) 2018-02-22

Similar Documents

Publication Publication Date Title
PH12019500330A1 (en) Porcine epidemic diarrhea preventative or therapeutic method, vaccine, and vaccine kit
BR112018013387A2 (pt) vetor de vacinação recombinante, vírus mva, vacina ou composição farmacêutica e kit
MX2016012845A (es) Vacuna contra el virus de la diarrea epidemica porcina.
BR112016028816A8 (pt) combinação imunogênica, método para obter uma resposta imunológica específica, uso de uma combinação imunogênica, e, regime de vacinação para prevenção, redução ou tratamento de infecção por vírus sincicial respiratório
CL2016002794A1 (es) Vacuna de péptido que comprende un péptido ras mutante y un agente quimioterapéutico
MX2017010908A (es) Vacuna bivalente contra el virus de gripe porcina.
MX2020004543A (es) Vacunas contra el zika, composiciones inmunogenicas y metodos que las utilizan.
BR112017002440A2 (pt) vírus da diarreia epizoótica porcina mutante para utilização em uma vacina
DOP2024000040A (es) Vacunas para vhb y métodos de tratamiento de vhb
ZA201901402B (en) Neisseria meningitidis vaccine
PH12015501716B1 (en) Anti-mycoplasma spp. subunit vaccine
IN2013MU00711A (es)
EA201691638A1 (ru) Новые способы индуцирования иммунного ответа
MX2018006416A (es) Metodos para el tratamiento, prevencion y diagnostico de infeccion por el virus de la diarrea epidemica porcina.
BR112015022582A2 (pt) molécula de ácido nucleico, plasmídeo, vacina, e, uso de um plasmídeo
MX2017013564A (es) Formulaciones de glucopiranosil lipido a y alérgenos de cacahuete para administración sublingual.
CL2018000513A1 (es) Vacunas de pestivirus para temblores congénitos
AR104271A1 (es) Vacuna contra las paperas en base al virus jeryl lynn 2 recombinante
MX2017006744A (es) Composiciones adyuvantes y metodos relacionados.
EP3549604A4 (en) RECOMBINANT BIVALENT INACTIVATED VACCINE FOR MOUTH AND MOUTH DISEASE AND THE MANUFACTURING PROCESS AND USE OF IT
EP3848048A4 (en) IMMUNITY STIMULANT, METHOD OF PRODUCTION THEREOF AND KIT AND VACCINE USING THE IMMUNITY STIMULANT
MX2020003753A (es) Composicion nasal de vacuna contra hepatitis b y metodo para producir la misma.
BR112017028052A2 (pt) peptídeo, método para induzir uma resposta imune em um sujeito e formulação de vacina
CY1119636T1 (el) Φαρμακευτικο παρασκευασμα με βαση διοσμεκτιτη
UA125050U (uk) Спосіб корекції проявів синдрому ендотоксикозу при психотичних станах